Treatment of hypertension in patients with chronic obstructive pulmonary disease

The article was professionally consulted with Master, Doctor Nguyen Huy Nhat - Respiratory Doctor - Department of Medical Examination & Internal Medicine - Vinmec Danang International General Hospital.

Chronic Obstructive Pulmonary Disease (COPD) is a chronic obstructive pulmonary disease that impairs ventilation. Airflow obstruction progresses with abnormal inflammation of the lungs due to noxious gases and particles. The disease will gradually reduce the lung ventilation function.
Over time, the disease will get worse, making normal daily activities such as walking, exercising become difficult. In addition, the patient has obvious symptoms such as shortness of breath, wheezing, chest tightness, frequent cough, phlegm in the neck, fatigue.

Co-morbidities are other comorbidities that often co-occur with chronic obstructive pulmonary disease. Comorbidities are preventable as well as treatable. Those are diseases that affect the environment outside the lungs that increase the severity of the disease.

If not detected in time, COPD and its comorbidities can increase the risk of medical events, increase the risk of hospitalization for comorbidities, and increase the risk of death due to comorbidities. co-morbid disease.

COPD and hypertension are closely related. Primary hypertension is often a comorbidity of chronic obstructive pulmonary disease. Blood pressure control in patients with chronic obstructive pulmonary disease (COPD) is a common problem because of the high prevalence of hypertension today.
The treatment of patients with chronic obstructive pulmonary disease is often very old, so when the disease is accompanied by high blood pressure, it is necessary to have different therapeutic goals with certain principles.

Currently, there are many antihypertensive drugs with different mechanisms of action that have been used by doctors. Some antihypertensive drugs when used can cause side effects on lung function; Therefore, the management of patients with chronic obstructive pulmonary disease with hypertension may have several therapeutic trials.
Controlling high blood pressure helps to deal with all the established risk factors for COPD: cardiovascular disease, dyslipidemia, impaired glucose tolerance or diabetes, and obesity. and smoke.
According to research, from the age of 80 onwards, systolic blood pressure <150mmHg will ensure the sustainability of cardiovascular and stroke. Therefore, a blood pressure goal of 150/90 mmHg is currently recommended for patients in this age group.
Patients with chronic obstructive pulmonary disease may require additional treatment for hypertension, lifelong treatment and can be dangerous if self-terminating medication or lifestyle changes without first consulting doctor's opinion.